A Prospective Prevalence Study in Adolescent and Adult Patients Dependent on Parenteral Nutrition to Assess the Incidence of Intestinal Failure-Associated Liver Disease
Latest Information Update: 21 Mar 2025
At a glance
- Drugs Choline chloride (Primary)
- Indications Liver disorders
- Focus Therapeutic Use
- Acronyms THRIVE-1
- Sponsors Protara Therapeutics
Most Recent Events
- 19 Mar 2025 According to a Protara Therapeutics media release, data from this study will be featured during an oral session at the American Society for Parenteral and Enteral Nutrition (ASPEN) 2025 Nutrition Science & Practice Conference, taking place March 22 through March 25, 2025 in Columbus, Ohio.
- 09 Sep 2024 According to a Protara Therapeutics media release, data from this trial presented at the 46th European Society for Clinical Nutrition and Metabolism Congress (ESPEN).
- 09 Sep 2024 Results published in the Protara Therapeutics Media Release